| __timestamp | Amicus Therapeutics, Inc. | Apellis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 47624000 | 8379522 |
| Thursday, January 1, 2015 | 76943000 | 13730311 |
| Friday, January 1, 2016 | 104793000 | 22978599 |
| Sunday, January 1, 2017 | 149310000 | 40303878 |
| Monday, January 1, 2018 | 270902000 | 105285576 |
| Tuesday, January 1, 2019 | 286378000 | 220968770 |
| Wednesday, January 1, 2020 | 308443000 | 299921000 |
| Friday, January 1, 2021 | 272049000 | 420869000 |
| Saturday, January 1, 2022 | 276677000 | 387236000 |
| Sunday, January 1, 2023 | 152381000 | 354387000 |
Unlocking the unknown
In the competitive world of biotechnology, research and development (R&D) investments are crucial for driving innovation and maintaining a competitive edge. Over the past decade, Apellis Pharmaceuticals, Inc. and Amicus Therapeutics, Inc. have demonstrated significant commitment to R&D, with both companies showing remarkable growth in their investments.
From 2014 to 2023, Apellis Pharmaceuticals increased its R&D spending by an impressive 4,130%, peaking in 2021 with a 420% increase compared to 2014. This surge underscores their dedication to pioneering treatments and advancing their pipeline.
Amicus Therapeutics also showed a robust increase in R&D investments, growing by 220% over the same period. Their peak investment occurred in 2020, marking a 547% increase from 2014. This consistent growth highlights their focus on developing therapies for rare diseases.
Both companies exemplify the biotech industry's relentless pursuit of innovation, with their R&D investments reflecting a commitment to transforming patient care.
R&D Insights: How Teva Pharmaceutical Industries Limited and Amicus Therapeutics, Inc. Allocate Funds
Research and Development Expenses Breakdown: Genmab A/S vs Amicus Therapeutics, Inc.
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Apellis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Madrigal Pharmaceuticals, Inc. and Apellis Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Ionis Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Amicus Therapeutics, Inc.
R&D Spending Showdown: Apellis Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. vs Dynavax Technologies Corporation: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and Xencor, Inc.
Viking Therapeutics, Inc. vs Amicus Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Amicus Therapeutics, Inc. vs HUTCHMED (China) Limited
Analyzing R&D Budgets: Amicus Therapeutics, Inc. vs Mesoblast Limited